Fuso Pharmaceutical IndustriesFuso Pharmaceutical Industries,Ltd.4538東証プライム医薬品FY ending Mar 2026, non-consolidated, J-GAAP

Fuso Pharmaceutical Industries FY ending Mar 2020 results

Fuso Pharmaceutical Industries brought in ¥46.9B in revenue.

Out of every ¥100 of sales, about ¥2 is left as operating profit.

Where the money goes

For every ¥100 Fuso Pharmaceutical Industries sells, how much goes where, and how much is kept.

FY ending Mar 2020

Margin funnel (derived from reported values)Gross margin 27.3% → Operating margin 2.2% → Net margin 1.5%

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第101期(2023/04/01－2024/03/31)
ID S100TRL62024-06-25Open
EDINET (FSA Japan)
有価証券報告書－第99期(令和3年4月1日－令和4年3月31日)
ID S100OL982022-06-29Open
EDINET (FSA Japan)
有価証券報告書－第98期(令和2年4月1日－令和3年3月31日)
ID S100LSH72021-06-29Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.